Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel
The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2009-07-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/15/7/08-0796_article |
_version_ | 1818413503276384256 |
---|---|
author | Shmuel Stienlauf Vered Yahalom Eli Schwartz Eilat Shinar Gad Segal Yechezkel Sidi |
author_facet | Shmuel Stienlauf Vered Yahalom Eli Schwartz Eilat Shinar Gad Segal Yechezkel Sidi |
author_sort | Shmuel Stienlauf |
collection | DOAJ |
description | The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic. |
first_indexed | 2024-12-14T11:04:14Z |
format | Article |
id | doaj.art-8969adbaf6114ab0b04d3f00e522d5b0 |
institution | Directory Open Access Journal |
issn | 1080-6040 1080-6059 |
language | English |
last_indexed | 2024-12-14T11:04:14Z |
publishDate | 2009-07-01 |
publisher | Centers for Disease Control and Prevention |
record_format | Article |
series | Emerging Infectious Diseases |
spelling | doaj.art-8969adbaf6114ab0b04d3f00e522d5b02022-12-21T23:04:37ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592009-07-011571116111810.3201/eid1507.080796Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, IsraelShmuel StienlaufVered YahalomEli SchwartzEilat ShinarGad SegalYechezkel SidiThe prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.https://wwwnc.cdc.gov/eid/article/15/7/08-0796_articleKeywords: HTLV-1 infectionshuman T-cell lymphotropic virus type 1virusesepidemiologyIsraelemigration and immigration |
spellingShingle | Shmuel Stienlauf Vered Yahalom Eli Schwartz Eilat Shinar Gad Segal Yechezkel Sidi Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel Emerging Infectious Diseases Keywords: HTLV-1 infections human T-cell lymphotropic virus type 1 viruses epidemiology Israel emigration and immigration |
title | Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel |
title_full | Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel |
title_fullStr | Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel |
title_full_unstemmed | Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel |
title_short | Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel |
title_sort | epidemiology of human t cell lymphotropic virus type 1 infection in blood donors israel |
topic | Keywords: HTLV-1 infections human T-cell lymphotropic virus type 1 viruses epidemiology Israel emigration and immigration |
url | https://wwwnc.cdc.gov/eid/article/15/7/08-0796_article |
work_keys_str_mv | AT shmuelstienlauf epidemiologyofhumantcelllymphotropicvirustype1infectioninblooddonorsisrael AT veredyahalom epidemiologyofhumantcelllymphotropicvirustype1infectioninblooddonorsisrael AT elischwartz epidemiologyofhumantcelllymphotropicvirustype1infectioninblooddonorsisrael AT eilatshinar epidemiologyofhumantcelllymphotropicvirustype1infectioninblooddonorsisrael AT gadsegal epidemiologyofhumantcelllymphotropicvirustype1infectioninblooddonorsisrael AT yechezkelsidi epidemiologyofhumantcelllymphotropicvirustype1infectioninblooddonorsisrael |